Skip to content
Search

Latest Stories

Smoking rates at record low, pharmacies seek funding to turbocharge reduction

Smoking rates at record low, pharmacies seek funding to turbocharge reduction

Community pharmacies urge the government to reverse cuts to local public health budgets and invest in stop smoking services

The Office for National Statistics (ONS) has released new data revealing that adult smoking rates in the UK have fallen to their lowest levels on record.

In 2023, only 11.9 per cent of adults aged 18 and over—approximately 6 million people—reported smoking cigarettes, marking the lowest proportion of smokers since the Annual Population Survey (APS) began in 2011.


Since 2011, the proportion of smokers has decreased by 8.3 percentage points from 20.2 per cent.

However, this change was not statistically significant when compared to the previous year’s rates, which was 12.9 per cent in 2022.

Among age groups, those aged 25 to 34 years had the highest smoking prevalence at 14.0 per cent in 2023.

Notably, the 18 to 24 age group experienced the largest reduction in smoking rates, dropping by 15.9 percentage points from 25.7 per cent in 2011 to 9.8per cent in 2023.

Commenting on the new ONS statistics, Paul Rees, CEO of the National Pharmacy Association (NPA), highlighted the importance of community pharmacies in combating smoking.

"For decades, community pharmacies across the UK have been instrumental in the fight against smoking. Through their locally commissioned services they have supported hundreds of thousands of people to help quit.

"It is good to see a reduction in levels of smoking. Smoking still remains of the biggest causes of ill health in our communities,” he said.

Rees noted, however, that cuts to local public health budgets by the central government have resulted in the decommissioning of some vital stop smoking services in community pharmacies.

"If we are to turbocharge this reduction in the rates of smoking, we need to reverse these cuts and invest in these services in our community pharmacies.

"Pharmacies should also be able to provide a nationally commissioned walk in smoking cessation service, which would end the postcode lottery for accessing support,” he said.

Rise in e-cigarette use

In contrast, e-cigarette use in Great Britain has risen, as indicated by the ONS data.

In 2023, around 5.1 million adults aged 16 and over (9.8 per cent) in Great Britain reported using e-cigarettes either daily or occasionally, based on the Opinions and Lifestyle Survey (OPN).

Daily e-cigarette usage among this demographic rose to 5.9 per cent, up from 5.2 per cent in 2022, while occasional use increased to 3.9 per cent, compared to 3.5per cent the previous year.

E-cigarette use was notably high among younger individuals, with 15.8 per cent of those aged 16 to 24 using them either daily or occasionally.

Regional variations in smoking prevalence were observed: 11.6 per cent in England, 12.6 per cent in Wales, 13.5 per cent in Scotland, and 13.3per cent in Northern Ireland.

Men continued to smoke more than women, with 13.7 per cent of men (approximately 3.4 million) and 10.1 per cent of women (around 2.6 million) identifying as current smokers in 2023.

The data also revealed disparities in smoking prevalence based on economic status.  Unemployed individuals had a higher proportion of current smokers (19.7 per cent), compared with those in paid employment (11.4 per cent) and those classified economically inactive (12.2 per cent).

Additionally, smoking rates were notably higher in routine and manual occupations (20.2 per cent) compared to managerial and professional roles (7.9 per cent).

More For You

NICE approves AstraZeneca’s twice-a-day tablet ‘capivasertib’ for advanced breast cancer

HR-positive, HER2-negative advanced breast cancer is currently incurable, and treatment aims to slow progression and prolong life

Gettyimages

NICE approves twice-a-day tablet for advanced breast cancer

Every year, thousands of people with hormone receptor (HR)-positive HER2-negative breast cancer could benefit from a new twice-a-day tablet, now set to be funded immediately through the Cancer Drugs Fund.

The National Institute for Health and Care Excellence (NICE) has approved the use of capivasertib (also known as Truqap), in combination with fulvestrant, as an option for around 1,100 adults with HR-positive HER2-negative breast cancer that has certain genetic mutations and has spread.

Keep ReadingShow less
ABPI and government fast-track VPAG scheme review to address high medicine payment rates

The 2025 VPAG payment rate for newer medicines has been set at 22.9 per cent.

Photo credit: gettyimages

Review of 2024 VPAG scheme to be completed by June

The Association of the British Pharmaceutical Industry (ABPI) and the government have agreed to bring forward a planned review of the 2024 Voluntary Scheme for Branded Medicines Pricing, Access, and Growth (VPAG), originally scheduled for autumn 2025.

The review is expected to be completed in June 2025, aligning with the anticipated release of the government’s 10-year NHS Plan and the Life Sciences Sector Plan as part of the broader industry strategy this summer.

Keep ReadingShow less
AAH upgrades ordering portal, making procurement easier for pharmacies

AAH Cascade compares prices and availability across suppliers

AAH Warehouse

AAH upgrades ordering portal to improve product visibility

Leading pharmaceutical wholesaler AAH Pharmaceuticals Ltd has introduced new digital functionalities to AAH Cascade, its independently managed ordering portal, making procurement easier and more cost-effective for pharmacies.

AAH Cascade compares product prices and availability across multiple suppliers, eliminating the need for manual searches.

Keep ReadingShow less
Majority of Brits neglect consistent skincare routine,  survey finds

On average, Brits go to bed without washing their face twice a week.

Photo credit: gettyimages

Skincare: One in five Brits go to bed without washing their face daily, survey finds

Nearly two-thirds of Brits (60 per cent) neglect a consistent skincare routine,with almost one in five going to bed without washing their face daily, according to a new survey by consumer health company Kenvue.

The UK-wide survey of 2,000 people revealed that one-third of respondents (34 per cent) spend five minutes or less on their daily skincare routine. On average, Brits go to bed without washing their face twice a week.

Keep ReadingShow less
Risk of pharmacy closures remains despite record funding uplift

Community pharmacy sector remains in a fragile position as the funding gap is still significant, says CCA.

gettyimages

Pharmacy closures still a risk as funding deal fails to cover costs – warns CCA

The community pharmacy sector has secured the largest funding uplift across the NHS, yet concerns remain that it may not be enough to prevent further closures and service reductions.

Following a six-week consultation with Community Pharmacy England (CPE), the government has approved a £3.073 billion funding package for 2025/26, supplemented by an additional £215 million to support Pharmacy First and other Primary Care Recovery Plan services.

Keep ReadingShow less